Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRI476 (Oxcarbazepine) as adjunctive therapy in children with partial onset seizures
NCT01051193Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jan 2010
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxcarbazepine in focal onset seizure, sponsored by Nobelpharma Co., Ltd.. Started Jan 2010; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT01051193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051193.